![Min-Chul Park](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Min-Chul Park
Directeur/Bestuurslid bij ZYVERSA THERAPEUTICS, INC.
Vermogen: - $ op 30-06-2024
Actieve functies van Min-Chul Park
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ZYVERSA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-12-2022 | - |
Independent Dir/Board Member | 01-12-2022 | - | |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Directeur/Bestuurslid | - | - |
Inje University | Corporate Officer/Principal | - | - |
Loopbaan van Min-Chul Park
Eerdere bekende functies van Min-Chul Park
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CURE BIO Co., Ltd.
![]() CURE BIO Co., Ltd. BiotechnologyHealth Technology CURE BIO Co., Ltd. ENGAGES in the research and development of therapeutic and diagnostic products through the use of aminoacyl tRNA synthetase. The company was founded in 2002 and is headquartered in Seoul, South Korea. | Directeur/Bestuurslid | 01-10-2020 | 01-04-2022 |
Algemeen Directeur | 01-10-2020 | 01-04-2022 | |
Neomics Co., Ltd.
![]() Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - |
Opleiding van Min-Chul Park
Seoul National University | Doctorate Degree |
Statistieken
Internationaal
Zuid-Korea | 5 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ZYVERSA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Neomics Co., Ltd.
![]() Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Neomics Co., Ltd. develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer. It provides services of custom antibody and protein production and offers antibody groups including in-house antibodies from aminoacyl-tRNA synthesize. The company was founded by Chi Uk In in 2005 and is headquartered in Seoul, South Korea. | Health Technology |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
CURE BIO Co., Ltd.
![]() CURE BIO Co., Ltd. BiotechnologyHealth Technology CURE BIO Co., Ltd. ENGAGES in the research and development of therapeutic and diagnostic products through the use of aminoacyl tRNA synthetase. The company was founded in 2002 and is headquartered in Seoul, South Korea. | Health Technology |
- Beurs
- Insiders
- Min-Chul Park
- Ervaring